| Literature DB >> 837060 |
Abstract
Electrocochleography was performed on three patients to monitor the intravenous administration of tobramycin. When peak serum tobramycin levels exceeded 8-10 mug/ml an immediate dramatic reduction in cochlear output was observed, which recovered fully as serum levels fell. The patients had no auditory or vestibular symptoms either during or after treatment.Entities:
Mesh:
Substances:
Year: 1977 PMID: 837060 PMCID: PMC1604140 DOI: 10.1136/bmj.1.6056.259
Source DB: PubMed Journal: Br Med J ISSN: 0007-1447